{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:05:24Z","timestamp":1791248724030,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.smim.2011.07.008","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T22:21:01Z","timestamp":1312582861000},"page":"462-468","source":"Crossref","is-referenced-by-count":85,"title":["Clinical perspectives for regulatory T cells in transplantation tolerance"],"prefix":"10.1016","volume":"23","author":[{"given":"Keli L.","family":"Hippen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl H.","family":"June","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2011.07.008_bib0005","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2011.07.008_bib0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10875-008-9242-z","article-title":"T regulatory cells in autoimmune diabetes: past challenges, future prospects","volume":"28","author":"Bluestone","year":"2008","journal-title":"Journal of Clinical Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2011.07.008_bib0025","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: take a billion or so and call me in the morning","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2011.07.008_bib0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.iy.10.040192.002001","article-title":"Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction","volume":"10","author":"Rosenberg","year":"1992","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0040","doi-asserted-by":"crossref","first-page":"83ps19","DOI":"10.1126\/scitranslmed.3001819","article-title":"Regulatory T cells: customizing for the clinic","volume":"3","author":"Wang","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0045","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1126\/science.332.6033.1020","article-title":"Immunology. Regulatory T cells get their chance to shine","volume":"332","author":"Leslie","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.smim.2011.07.008_bib0050","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2004-01-0151","article-title":"In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures","volume":"104","author":"Godfrey","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0060","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","article-title":"Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease","volume":"11","author":"Hippen","year":"2011","journal-title":"American Journal of Transplantation: Official Journal of the American Society of Transplantation and The American Society of Transplant Surgeons"},{"key":"10.1016\/j.smim.2011.07.008_bib0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbmt.2006.01.005","article-title":"Isolation of CD4+ CD25+ regulatory T cells for clinical trials","volume":"12","author":"Hoffmann","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.smim.2011.07.008_bib0070","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0075","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2008-01-132951","article-title":"Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells","volume":"112","author":"Hippen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0080","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+ CD25+ FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0085","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0090","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood-2005-07-3032","article-title":"Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+ CD25+ regulatory T cells","volume":"107","author":"Coenen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4049\/jimmunol.178.1.320","article-title":"Selective survival of naturally occurring human CD4+ CD25+ Foxp3+ regulatory T cells cultured with rapamycin","volume":"178","author":"Strauss","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0100","doi-asserted-by":"crossref","first-page":"78ra33","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0105","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.4049\/jimmunol.181.3.1798","article-title":"Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells","volume":"181","author":"Godebu","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0110","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.4049\/jimmunol.180.5.2830","article-title":"Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance","volume":"180","author":"Selvaraj","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbmt.2010.12.710","article-title":"Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice","volume":"17","author":"Semple","year":"2011","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"key":"10.1016\/j.smim.2011.07.008_bib0120","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.179.6.3724","article-title":"Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells","volume":"179","author":"Kang","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0125","doi-asserted-by":"crossref","first-page":"e15868","DOI":"10.1371\/journal.pone.0015868","article-title":"Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells","volume":"6","author":"Golovina","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2011.07.008_bib0130","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1164511","article-title":"Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero","volume":"322","author":"Mold","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.smim.2011.07.008_bib0135","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","article-title":"Induction of FOXP3 expression in naive human CD4+ FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype","volume":"110","author":"Tran","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0140","doi-asserted-by":"crossref","first-page":"e15150","DOI":"10.1371\/journal.pone.0015150","article-title":"Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-beta and retinoic acid","volume":"5","author":"Lu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2011.07.008_bib0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.smim.2011.07.008_bib0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.mt.6300341","article-title":"Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3","volume":"16","author":"Allan","year":"2008","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.smim.2011.07.008_bib0155","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/eji.200526077","article-title":"Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation","volume":"35","author":"Albert","year":"2005","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.179.2.493","article-title":"High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells","volume":"179","author":"Bacchetta","year":"1994","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2011.01010.x","article-title":"Clinical tolerance in allogeneic hematopoietic stem cell transplantation","volume":"241","author":"Roncarolo","year":"2011","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.smim.2011.07.008_bib0170","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3324\/haematol.2008.003129","article-title":"Type 1 regulatory T cells are associated with persistent split erythroid\/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia","volume":"94","author":"Serafini","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.smim.2011.07.008_bib0175","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.163.7.3684","article-title":"Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta","volume":"163","author":"Zeller","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V114.22.45.45","article-title":"Interleukin-10 anergized donor T cell infusion improves immune reconstitution without severe graft-versus-host-disease after haploidentical hematopoietic stem cell transplantation","volume":"114","author":"Bacchetta","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0185","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0190","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+ CD25+ CD127\u2212 T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0200","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3324\/haematol.2010.025825","article-title":"Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy","volume":"95","author":"Bacchetta","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.smim.2011.07.008_bib0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bmt.1703779","article-title":"Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study","volume":"31","author":"Lewalle","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.smim.2011.07.008_bib0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0215","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.181.4.2855","article-title":"CD28 costimulation is essential for human T regulatory expansion and function","volume":"181","author":"Golovina","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0220","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0225","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/db08-1168","article-title":"Expansion of human regulatory T-cells from patients with type 1 diabetes","volume":"58","author":"Putnam","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.smim.2011.07.008_bib0230","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1182\/blood-2009-01-199950","article-title":"Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I\/II (CD121a\/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures","volume":"113","author":"Tran","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.smim.2011.07.008_bib0240","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1126\/science.1186068","article-title":"Protein kinase C-theta mediates negative feedback on regulatory T cell function","volume":"328","author":"Zanin-Zhorov","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.smim.2011.07.008_bib0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI43706","article-title":"Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice","author":"Ma","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.smim.2011.07.008_bib0250","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2009-11-252825","article-title":"Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses","volume":"116","author":"Vogtenhuber","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0255","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.176.8.4622","article-title":"MHC class II expression identifies functionally distinct human regulatory T cells","volume":"176","author":"Baecher-Allan","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0260","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+ CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0265","doi-asserted-by":"crossref","first-page":"13974","DOI":"10.1073\/pnas.0906872106","article-title":"CD4+ CD25\u2212 LAG3+ regulatory T cells controlled by the transcription factor Egr-2","volume":"106","author":"Okamura","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.smim.2011.07.008_bib0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.smim.2011.07.008_bib0275","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/eji.200535445","article-title":"Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire","volume":"36","author":"Fisson","year":"2006","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0280","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/eji.200939432","article-title":"Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD","volume":"39","author":"Koenecke","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.smim.2006.01.004","article-title":"Antigen-specific regulatory T cells\u2014ex vivo expansion and therapeutic potential","volume":"18","author":"Masteller","year":"2006","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0290","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.175.5.3053","article-title":"Expansion of functional endogenous antigen-specific CD4+ CD25+ regulatory T cells from nonobese diabetic mice","volume":"175","author":"Masteller","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0295","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.smim.2011.07.008_bib0300","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/01.TP.0000106470.07410.CA","article-title":"Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation","volume":"77","author":"Trenado","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.smim.2011.07.008_bib0305","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.0105-2896.2006.00422.x","article-title":"Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity","volume":"212","author":"Yamazaki","year":"2006","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.smim.2011.07.008_bib0310","doi-asserted-by":"crossref","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0315","doi-asserted-by":"crossref","first-page":"e11726","DOI":"10.1371\/journal.pone.0011726","article-title":"Human antigen-specific regulatory T cells generated by T cell receptor gene transfer","volume":"5","author":"Brusko","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2011.07.008_bib0320","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.0903940","article-title":"Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells","volume":"185","author":"Barron","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0325","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0330","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.4049\/jimmunol.1100061","article-title":"IL-2 controls the stability of Foxp3 expression in TGF-\u03b2-induced Foxp3+ T cells in vivo","volume":"186","author":"Chen","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2009-12-257253","article-title":"In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia","volume":"116","author":"Choi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0340","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2009-05-219584","article-title":"Epigenetic mechanisms of regulation of Foxp3 expression","volume":"114","author":"Lal","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0345","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0350","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/eji.200838913","article-title":"IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis","volume":"39","author":"Chang","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0355","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0360","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0365","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells","volume":"101","author":"Latchman","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.smim.2011.07.008_bib0370","doi-asserted-by":"crossref","first-page":"e1000302","DOI":"10.1371\/journal.pbio.1000302","article-title":"Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1","volume":"8","author":"Amarnath","year":"2010","journal-title":"PLoS Biology"},{"key":"10.1016\/j.smim.2011.07.008_bib0375","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.4049\/jimmunol.181.8.5396","article-title":"The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive t regulatory cell generation","volume":"181","author":"Chen","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0380","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.smim.2011.07.008_bib0385","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1172\/JCI31911","article-title":"Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase","volume":"117","author":"Sharma","year":"2007","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.smim.2011.07.008_bib0390","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1182\/blood-2009-06-227587","article-title":"Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality","volume":"114","author":"Jasperson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0395","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood-2007-06-096081","article-title":"Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality","volume":"111","author":"Jasperson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0400","first-page":"2562","article-title":"Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice","volume":"118","author":"Reddy","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.smim.2011.07.008_bib0405","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1182\/blood-2008-06-161026","article-title":"Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment","volume":"113","author":"Swee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0410","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2011.07.008_bib0415","doi-asserted-by":"crossref","first-page":"83ra40","DOI":"10.1126\/scitranslmed.3002099","article-title":"Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection","volume":"3","author":"Feng","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0420","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbmt.2007.01.071","article-title":"Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo","volume":"13","author":"O'Shaughnessy","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.smim.2011.07.008_bib0425","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2011.07.008_bib0430","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2011.07.008_bib0435","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1073\/pnas.0811556106","article-title":"Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity","volume":"106","author":"Komatsu","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.smim.2011.07.008_bib0440","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.immuni.2009.04.009","article-title":"Control of regulatory T cell lineage commitment and maintenance","volume":"30","author":"Josefowicz","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2011.07.008_bib0445","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20070109","article-title":"CREB\/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation","volume":"204","author":"Kim","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.smim.2011.07.008_bib0450","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db07-1460","article-title":"Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta","volume":"57","author":"Richer","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.smim.2011.07.008_bib0455","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nature Reviews Immunology"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532311000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532311000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T11:25:27Z","timestamp":1686223527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532311000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1044532311000649"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2011.07.008","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}